Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 8, 2018—Seasoned Pharmaceutical Executive Elizabeth McKee Anderson Appointed as New Director—
-
Nov 6, 2018
-
Oct 30, 2018—Quarter Highlighted by U.S. FDA Approval of ARIKAYCE® (amikacin liposome inhalation suspension), Followed by Immediate Launch—
-
Oct 23, 2018
-
Oct 4, 2018New Patent Adds 7 ½ Years of Market Exclusivity in Japan
-
Oct 1, 2018
-
Sep 28, 2018Commercial availability expected in early Q4 2018
-
Sep 17, 2018As previously reported, study met primary endpoint of culture conversion (p<0.0001)
Your Privacy Choices